Galderma Research & Development
8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 9 name spellings.
19
Ending by 2030
Jul 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Dec 9 to 23, 2026 · next Dec 9
- 2 fees due Jan 9 to 21, 2027 · next Jan 9
- 4 fees due Feb 11 to 22, 2027 · next Feb 11
- 2 fees due Mar 1 to 15, 2027 · next Mar 1
- 2 fees due Apr 22 to 29, 2027 · next Apr 22
- 1 fee due Aug 4, 2027The maintenance fee for Tetrahydroquinoline sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (t)) (US 10,550,110) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.
- 1 fee due Sep 1, 2027The maintenance fee for Dermatological foams obtained from a gel or suspension containing adapalene (US 9,271,930) comes due Sep 1, 2027. Unpaid by Mar 1, 2028, it lapses early.
Recent changes
- 5 terms have ended since Aug 23, 2026
- Oct 27 US 7,767,650 Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof · term ended
- Oct 7 US 8,853,275 Concurrent Therapy Regime/Regimen for the Treatment of Acne Related Diseases · lapsed on the fee record
- Sep 15 US 8,709,392 Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers · term ended
- Sep 15 US 8,435,502 Cosmetic/dermatological compositions comprising naphtholic acid compounds and polyurethane polymers · term ended
- Sep 4 US 10,067,144 Antibodies Against Human Sodium Channel Nav 1.9 · lapsed on the fee record
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,060,948 | Dermatological/cosmetic compositions comprising a retinoid and benzoyl peroxide In force · USPTO record | In force | USPTO record | |
| US 8,080,537 | Combinations of adapalene and benzoyl peroxide for treating acne lesions In force · USPTO record | In force | USPTO record | |
| US 8,071,644 | Combinations of Adapalene and Benzoyl Peroxide for Treating Acne Lesions In force · Medium confidence | In force | Medium confidence | |
| US 7,872,026 | Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof In force · USPTO record | In force | USPTO record | |
| US 7,998,467 | Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers In force · USPTO record | In force | USPTO record | |
| US 8,758,805 | Skin moisturizing compositions In force · USPTO record | In force | USPTO record | |
| US 8,044,082 | N-phenylacetamide inhibitors of the enzyme SOAT-1 and pharmaceutical/cosmetic compositions comprised thereof In force · USPTO record | In force | USPTO record | |
| US 8,957,112 | Cream gels comprising at least one retinoid and benzoyl peroxide In force · Medium confidence | In force | Medium confidence | |
| US 8,937,098 | Dermatological Compositions Comprising at Least One Naphthoic Acid Compound and at Least One Film-Forming Agent and Treatment of Keratinization Disorders Therewith In force · High confidence | In force | High confidence | |
| US 8,952,066 | Pharmaceutical/Cosmetic, E.G., Anti-Acne Compositions Comprising at Least One Naphthoic Acid Compound, Benzoyl Peroxide and at Least One Film-Forming Agent In force · High confidence | In force | High confidence |
Also on record, not counted in the 47: 8 patents in force now held by others · 171 lapsed for an unpaid fee · 45 ended at full term · 1 past the fee grace period. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
13 abandoned · 186 no status recorded
Rows 11 to 60 of 199 are for members. The first 10 are on the company page.
Pro members see all 199 published applications.